IQVIA Holdings (IQV) 10-K Summary — Year Ended Dec 31, 2023
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company reported revenue growth for the year, with operating income and net income reflecting its financial performance.
Key takeaway
Year ended Dec 31, 2023 · FY2025 10-K
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company reported revenue growth for the year, with operating income and net income reflecting its financial performance.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$15B
Revenue reported for the fiscal year.
Operating income
$2B
Income from operations reported for the year.
Net income
$1.4B
Net income reported for the year.
Operating cash flow
$2.1B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $13.9B | n/a |
| Dec 31, 2022 | $14.4B | +3.9% |
| Dec 31, 2023 | $15B | +4.0% |
Business overview
IQVIA is a global provider of analytics, technology, and clinical research services to the life sciences sector. It leverages a large collection of healthcare data and privacy-enhancing technologies to help clients accelerate drug development and commercialization. The company operates in over 100 countries with approximately 87,000 employees.
Financial performance
Revenue increased compared to the prior year. Operating income and net income were reported at levels consistent with the company's scale. Cash flow from operations was also reported.
Material risks
The filing references forward-looking statements subject to known and unknown risks and uncertainties that could cause actual results to differ. Specific risk factors are listed in the filing but not detailed in the provided context. The company faces general market and operational risks common to its industry.
Liquidity and capital
The company has a stock repurchase program authorized by its board, with recent increases in authorization. Repurchases are made based on market conditions and corporate requirements.
What to watch
Readers should monitor any changes in the company's revenue growth trajectory and operating margins in the next filing.